Summary Xplico Valuation Survey

By |November, 2018|

Discount Rate versus Affiliation

In July and August 2018 Xplico conducted a survey among 600 industry professionals about valuation in the life science industry and received 79 responses. We hereby present the results of the survey.

PDF: Summary Xplico Valuation Survey – with graphs.

Xplico article for Biotech & Money / LSX

By |October, 2018|

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Finn Nikolajsen, gives his point of view on the challenges of the ownership structures that the biotech companies and their investors face when they try to analyze the consequences of current and future funding rounds and exits:

Link to the article:

https://www.lsxleaders.com/blog/addressing-the-challenges-of-ownership-structures-in-life-sciences

Xplico named “a 2018 Gazelle Company” (a growth company) for the third year in a row by the leading Danish business newspaper Børsen.

By |October, 2018|

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2018 Gazelle Company for the 3rd year in a row. Børsen analyses every year all the Danish companies to identify growth companies. A Gazelle company is defined by the growth in revenue every year for a minimum of four consecutive years. Further, the revenue needs to be doubled in the period of four years and the company must generate a profit. We plan to stay on the Gazelle list for the coming years.

 

(September 2018)

XIV International Pharma Licensing Symposium, Montreux, Switzerland, September 19-21, 2018

By |September, 2018|

XIV International Pharma Licensing Symposium, Montreux, Switzerland, September 19-21, 2018

Please meet us at the  XIV International Pharma Licensing Symposium that will take place at Fairmont Le Montreux Palace in the stunning surroundings of Montreux, Switzerland. The event allows for the opportunity to hold pre-arranged partnering meetings and attend the presentations from high-calibre key note speakers. Participants also have the option of joining one of two additional training workshops being run in parallel to the one-to-one meetings.

Xplico article for Biotech & Money / LSX

By |August, 2018|

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, gives his point of view on the challenges that the Nordic life science companies face.

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team

By |August, 2018|

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team as Executive Assistant and will be working closely together with the partners Uffe Boesen and Finn Nikolajsen.
Sisse holds a Master’s Degree in International Business Relations and has more than 18 years of experience from Sales Management (B2C and B2B) and Business Administration. She has previous experience as both Executive Assistant and Personal Assistant and has worked with business development, sales management, market analysis and financial research in Denmark, France and USA.

LSX World Congress USA in Boston, October 10-11, 2018

By |August, 2018|

LSX World Congress USA in Boston, October 10-11, 2018


Please meet us at the LSX World Congress USA in Boston. LSX World Congress USA is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.

BIO-Europe 2018, Copenhagen, Denmark, November 5-7, 2018

By |August, 2018|

BIO-Europe 2018, Copenhagen, Denmark, November 5-7, 2018

Please meet us at the 2018 International Partnering Conference in our hometown Copenhagen, Denmark. BIO-Europe is Europe’s largest partnering conference, serving the global biotechnology industry. The conference annually attracts international leaders from biotech, pharma and finance along with the most promising start-ups and emerging companies.

Biofit 2018, Lille, France, December 4-5, 2018

By |August, 2018|

Biofit 2018, Lille, France, December 4-5, 2018

Please meet us at 2018 Biofit conference in Lille. BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences

Biotech Showcase 2019, San Francisco, USA, January 7–9, 2019

By |August, 2018|

Biotech Showcase 2019, San Francisco, USA, January 7–9, 2019


Please meet us at the 2019 Biotech Showcase in San Francisco. The investor and networking conference for public and private biotech companies to meet with and present to investors and pharmaceutical executives during the course of the healthcare industry’s most important week of the year.

BIO-Europe Spring 2019, Vienna, Austria, March 25 – 27, 2019

By |August, 2018|

BIO-Europe Spring 2019, Vienna, Austria, March 25 – 27, 2019


Please meet us at the 2019 BIO-Europe Spring Partnering Conference in Vienna, Austria. With a focus on European innovation and global collaboration, BIO-Europe Spring is the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in the most innovative biopharma clusters in Europe

Xplico Interview with Biotech & Money / LSX

By |July, 2018|

In an interview with Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, explains how valuation is critical for strategic decision-making and points out to some of the common pitfalls companies encounter when using valuation models that are built in house.
The link to the interview: Xplico: supporting strategic decision-making through life science valuations

Xplico named “a 2017 Gazelle Company” (a growth company) for the second year in a row by the leading Danish business newspaper Børsen.

By |February, 2018|

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2017 Gazelle Company for the 2nd year in a row. Børsen analyses every year all the Danish companies to identify growth companies. A Gazelle company is defined by the growth in revenue every year for a minimum of four consecutive years. Further, the revenue needs to be doubled in the period of four years and the company must generate a profit. We plan to stay on the Gazelle list for the coming years.

 

(September 2017)

Xplico named “a 2016 Gazelle Company” (a growth company) by the leading Danish business newspaper Børsen.

By |January, 2017|

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2016 Gazelle Company. Børsen analyses every year all the Danish companies to identify growth companies. A Gazelle company is defined by the growth in revenue every year for a minimum of 4 consecutive years. Further, the revenue needs to be doubled in the period of 4 years and the company must generate a profit. We plan to stay on the Gazelle list for the coming years.
(September 2016)

Xplico is pleased to announce that Peter Abelin has joined our valuation team.

By |January, 2017|

Xplico is pleased to announce that Peter Abelin has joined our valuation team.
Peter has more than 25 years’ experience from the life science industry working with equity portfolio management, financial research and pharmaceutical development at Swedbank Robur, AMF Pension, SEB Enskilda, Astra AB and as an MD. Peter brings a lot of expertise in assessing equity investments and life science equity valuation and will work closely with our clients valuating their business. Peter has combined his MD with BSc Econ and CE Financial Analyst.

skaermbillede-2017-01-04-kl-16-01-04
(June 2016)

Xplico launches Xplico Captable – a cap table providing simulations and waterfall analysis of the various stakeholders’ investments and values in a company.

By |January, 2017|

Xplico Captable is a capitalization table providing simulations and waterfall analysis of the founders’ and investors’ percentage of ownership, equity dilution, and value of equity in connection with (potential) funding rounds and exits. Xplico Captable has been successfully tested and reviewed by a number of companies including 2 of the Big 4 accounting companies. Xplico Captable is a very flexible and easy to use Excel-based tool and can be managed with very limited training. We ensure you the necessary support and backup as part of our Xplico Captable Package.

(January 2017)

BIO-Europe Spring 2017

By |November, 2016|

BIO-Europe Spring 2017, Barcelona, Spain, March 20 – 22, 2018

Please meet us at BIO-Europe Spring Partnering Conference in Barcelona Spain. BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high calibre partnering opportunities.

Deal supported by Xplico

By |October, 2016|

PharmaMar and Boryung Pharm sign a licensing agreement for Aplidin® (plitidepsin) in Korea.

Deal supported by Xplico

By |October, 2016|

Nuevolution Announces Strategic Collaboration with Amgen in Oncology and Neuroscience.

Deal supported by Xplico

By |October, 2016|

Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy.

Deal supported by Xplico

By |October, 2016|

TRACON Pharmaceuticals Announces a Strategic Licensing Collaboration for Two Janssen Oncology Assets and a $5 Million Equity Investment from Johnson & Johnson Innovation – JJDC, Inc.

BIO International Convention

By |October, 2016|

2017 BIO International Convention, San Diego, USA, June 19-22, 2017

Please meet us at the 2016 BIO International Convention in San Francisco, USA. The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

Spin-out supported by Xplico

By |September, 2016|

4SC sells immunology portfolio to Immunic

BioPharm America

By |September, 2016|

BioPharm America 2017, Boston, MA, USA, September 26–27, 2017


Please meet us at the 2017 BioPharm America in Boston. BioPharm America is the only event in North America based on the same reputable formula as European events BIO-Europe and BIO-Europe Spring.